Vulvar Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

Stereotactic Ablative Radiotherapy (SABR) in Combination With Durvalumab and Tremelimumab in Patients With Cervical, Vaginal, or Vulvar Cancer
Conditions:   Malignant Neoplasms of Female Genital Organs;   Cervical Cancer;   Vaginal Cancer;   Vulvar Cancer Interventions:   Drug: Durvalumab;   Drug: Tremelimumab;   Radiation: Stereotactic Ablative Radiotherapy (SABR) Sponsors:   M.D. Anderson Cancer Center;   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2018 Category: Research Source Type: clinical trials